missing translation for 'onlineSavingsMsg'
Learn More
Learn More
LGI3 Polyclonal Antibody, Invitrogen™
Rabbit Polyclonal Antibody
Brand: Invitrogen PA520494
This item is not returnable.
View return policy
Description
A suggested positive control is human brain tissue lysate. PA5-20494 can be used with blocking peptide PEP-0614.
The leucine-rich, glioma inactivated gene 3 (LGI3) is a member of the LGI family in which LGI1 is the exemplar. The LGI family consists of four of highly related proteins containing leucine-rich repeats (LRRs) which are highly similar to other transmembrane signaling molecules and receptors. LGI1 has been identified as a candidate tumor suppressor gene for glioma and plays a role in autodominant lateral temporal epilepsy (ADTLE), an epileptic syndrome characterized by focal seizures with predominant auditory symptoms. Despite its high homology with LGI1 and similar pattern of expression, mutations in LGI3 have not been found to be associated with ADTLE. LGI3 expression is induced in rat astrocyte cultures by the amyloid beta (Abeta) peptide and accumulated on neuronal plasma membranes of aged monkey brains and co-localized with Abeta.
Specifications
LGI3 | |
Polyclonal | |
Unconjugated | |
Lgi3 | |
AI841179; AW049851; Leubrin; leucine rich repeat LGI family member 3; leucine-rich glioma-inactivated protein 3; Leucine-rich repeat LGI family member 3; leucine-rich repeat LGI family, member 3; LGI1-like protein 4; LGI3; LGIL4; UNQ8190/PRO23199 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
203190, 213469, 306013 | |
Maintain refrigerated at 2-8°C for up to 3 months. For long term storage store at -20°C | |
Liquid |
Western Blot | |
1 mg/mL | |
PBS with 0.02% sodium azide | |
Q8K406, Q8N145 | |
Lgi3 | |
a 12 amino acid peptide from near the center of human LGI3. | |
100 μg | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction